Trygve Holmøy

Randomized trial of daily high-dose vitamin D ₃ in patients with RRMS receiving subcutaneous interferon β-1a

Raymond Hupperts, Joost Smolders, Reinhold Vieth et al. · Neurology · 2019 · 132 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

High‐throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV‐reactive CD8⁺ T cells

Andreas Lossius, Jorunn N. Johansen, Frode Vartdal et al. · European Journal of Immunology · 2014 · 126 citations

Life Sciences, Immunology, Neurology +17

Prevalence and Characteristics Associated With Post–COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults

Joel Selvakumar, Lise Beier Havdal, Martin Drevvatne et al. · JAMA Network Open · 2023 · 119 citations · Full text

Public Health, Infectious Diseases, Adolescent Health +14

Efficacy of vitamin D3 as add-on therapy in patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial

Joost Smolders, Raymond Hupperts, Frederik Barkhof et al. · Journal of the Neurological Sciences · 2011 · 114 citations

Pharmacy, Neurology, Pharmacotherapy +17

Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study

Kristin Wesnes, Trond Riise, Ilaria Casetta et al. · Multiple Sclerosis Journal · 2014 · 112 citations · Full text

Public Health, Population Health Sciences, Clinical Epidemiology +13